In Brief: Nasal sleep-aid
This article was originally published in The Tan Sheet
Executive Summary
Nasal sleep-aid: Nastech files IND with FDA to begin clinical trials on a nasal delivery formulation of doxylamine succinate as a sleep-aid. The Hauppauge, N.Y. R&D firm said it is currently discussing with FDA whether the nasal spray should be pursued as an OTC or prescription product. Nastech expects to test five different doses of the spray to determine the lowest effective dose...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning